Q32 Bio
QTTB
QTTB
106 hedge funds and large institutions have $343M invested in Q32 Bio in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.48% less ownership
Funds ownership: 4.2% → 3.73% (-0.48%)
6% less capital invested
Capital invested by funds: $364M → $343M (-$21.5M)
76% less call options, than puts
Call options by funds: $659K | Put options by funds: $2.75M
Holders
106
Holding in Top 10
2
Calls
$659K
Puts
$2.75M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$7.18M | |
| 3 | +$5.56M | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$901K |
| 5 |
PAM
Premier Asset Management
Chicago,
Illinois
|
+$871K |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$11.3M | |
| 3 | -$9.46M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.45M |
| 5 |
Goldman Sachs
New York
|
-$5.14M |